Last Update 20 Mar 26
Fair value Increased 5.00%EVLV: Expanded Stadium And Hospital Contracts Will Support Multi Year Upside
Analysts have nudged their price target for Evolv Technologies Holdings up from $10.00 to $10.50. They point to updated assumptions around slightly higher revenue growth, a marginally lower discount rate, and a modestly lower future P/E as key drivers of the change.
What's in the News
- Evolv renewed and expanded its subscription agreement with the Houston Astros, upgrading to Express Gen2 systems across Daikin Park and adding eXpedite bag screening. The company now serves all four major league teams in Houston and twelve professional baseball teams globally (Client Announcements).
- The Tennessee Titans renewed their Evolv Express subscription, upgrading 17 systems at Nissan Stadium to Express Gen2 under an agreement that covers both the current and future 60,000 seat domed stadium. Existing customers accounted for about half of Evolv’s business in Q1 2025 (Client Announcements).
- Evolv raised its 2026 total revenue guidance to a range of US$172m to US$178m, compared with prior guidance of US$160m to US$165m (Corporate Guidance).
- Bank of America Stadium extended and expanded its multi year Evolv Express and eXpedite subscription, upgrading nearly twenty Express systems to Gen2 hardware in time for Charlotte FC’s March 7, 2026 home opener (Client Announcements).
- Evolv was selected by the American Hospital Association as a Preferred Physical Security Provider, following a multi step vetting process, and currently partners with over 500 hospital buildings that collectively screen more than 900,000 visitors and staff each day (Client Announcements).
Valuation Changes
- Fair Value: Target nudged from $10.00 to $10.50. This reflects a small upward adjustment in the modeled equity value.
- Discount Rate: Assumption edged down slightly from 8.43% to 8.41%. This modestly increases the weight placed on future cash flows.
- Revenue Growth: Forecast moved from 20.41% to 22.33%. This indicates a slightly higher expected top line expansion in the model.
- Net Profit Margin: Assumption is effectively unchanged at about 8.08%. This suggests a similar profitability profile in the updated case.
- Future P/E: Valuation multiple trimmed from 138.99x to 135.73x. This indicates a marginally lower earnings multiple applied to future results.
Key Takeaways
- Surging regulatory mandates and expanding venue categories are set to accelerate adoption, greatly enlarging recurring revenue streams and addressable markets ahead of analyst expectations.
- Operational improvements and new product launches strengthen scalability, boost customer retention, and support margin expansion through increased cross-selling and higher customer value.
- Heightened regulatory, operational, and competitive pressures, along with ongoing high costs and business model shifts, threaten Evolv's growth, margins, and long-term profitability.
Catalysts
About Evolv Technologies Holdings- Provides artificial intelligence (AI)-based weapons detection for security screening in the United States and internationally.
- While analysts broadly agree that Evolv's low market penetration (below 10% in key verticals) presents long-term opportunity, the true addressable market is likely dramatically understated as rising global threats and expanding categories of venues-such as distribution warehouses, transportation sites, and international markets-push adoption well beyond school, hospital, and entertainment settings, fueling a multi-fold acceleration in recurring revenue potential over the next decade.
- Analyst consensus highlights the impact of regulatory changes like California's mandate for hospital security screening, but this likely underestimates the speed and magnitude of nationwide and potentially international legislation expected in the wake of escalating high-profile incidents, which could drive an exponential increase in mandatory deployments and sustained, higher-margin recurring revenue far sooner than forecast.
- The combination of accelerating urbanization and the global normalization of AI-based automation will drive widespread, mainstream adoption of touchless weapons detection, removing many historical barriers to large-scale deployment and materially increasing total addressable market size, thus compounding revenue growth well into the future.
- Evolv's recent leadership overhaul, operational realignment, and robust rebound in customer retention post-FTC inquiry have created a significantly more scalable and resilient organizational platform; this positions the company to unlock higher operating leverage and margin expansion much faster than anticipated as recurring-revenue growth compounds.
- The launch of new offerings such as the Certified Pre-Owned program and eXpedite not only expands addressable segments-including price-sensitive customers and those needing enhanced screening-but also accelerates cross-selling within the existing base, increasing net customer lifetime value, driving ARR, and supporting higher long-term earnings than generally expected.
Evolv Technologies Holdings Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- This narrative explores a more optimistic perspective on Evolv Technologies Holdings compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
- The bullish analysts are assuming Evolv Technologies Holdings's revenue will grow by 22.3% annually over the next 3 years.
- The bullish analysts are not forecasting that Evolv Technologies Holdings will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Evolv Technologies Holdings's profit margin will increase from -22.7% to the average US Electronic industry of 8.1% in 3 years.
- If Evolv Technologies Holdings's profit margin were to converge on the industry average, you could expect earnings to reach $21.6 million (and earnings per share of $0.1) by about March 2029, up from -$33.1 million today.
- In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 136.2x on those 2029 earnings, up from -29.7x today. This future PE is greater than the current PE for the US Electronic industry at 29.4x.
- The bullish analysts expect the number of shares outstanding to grow by 7.0% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 8.41%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Significant public and legislative scrutiny around surveillance, AI-based security, and data privacy could increase regulatory risk for Evolv's solutions, potentially limiting adoption and shrinking market opportunity-which would in turn constrain revenues and long-term revenue growth.
- Rapid advances in alternative security technologies, such as biometrics or drone surveillance, and intensifying competition from both incumbents and new entrants may erode Evolv's competitive advantage, creating pricing pressure and threatening revenue growth and margins.
- Recent operational challenges-including an FTC inquiry, a financial restatement that shifted $3.1 million in revenue, and a full overhaul of the executive team-signal governance and internal control weaknesses, which could undermine investor confidence and weigh on valuation and earnings multiples.
- Persistent high operating expenses, ongoing restructuring costs, required heavy R&D investment to stay ahead of evolving threats, and the need for substantial capital expenditures to support hardware subscription growth could compress gross margins and limit net margins for an extended period.
- Earnings visibility may be impeded by the shift to pure subscription models, slower ramp-up in recurring SaaS revenues versus traditional hardware sales, and the challenge of maintaining rapid subscriber growth, all of which increase risk to future revenue, cash flow generation, and long-term profitability.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The assumed bullish price target for Evolv Technologies Holdings is $10.5, which represents up to two standard deviations above the consensus price target of $10.0. This valuation is based on what can be assumed as the expectations of Evolv Technologies Holdings's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
- In order for you to agree with the more bullish analyst cohort, you'd need to believe that by 2029, revenues will be $267.1 million, earnings will come to $21.6 million, and it would be trading on a PE ratio of 136.2x, assuming you use a discount rate of 8.4%.
- Given the current share price of $5.5, the analyst price target of $10.5 is 47.7% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Evolv Technologies Holdings?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.



